UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

The American journal of gastroenterology, 2010-03, Vol.105 (3), p.501-523

2010

Link zum Volltext

Verfügbarkeit prüfen

The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement

The American journal of gastroenterology, 2024-06, Vol.119 (6), p.1001-1006

2024

Link zum Volltext

Verfügbarkeit prüfen

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

The New England journal of medicine, 2010-04, Vol.362 (15), p.1383-1395

2010

Link zum Volltext

Verfügbarkeit prüfen

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Gastroenterology (New York, N.Y. 1943), 2007-10, Vol.133 (4), p.1099-1105

2007

Link zum Volltext

Verfügbarkeit prüfen

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

The American journal of gastroenterology, 2004-07, Vol.99 (7), p.1371-1385

2004

Link zum Volltext

Verfügbarkeit prüfen

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

The American journal of gastroenterology, 2006-10, Vol.101 (10), p.2218-2222

2006

Link zum Volltext

Verfügbarkeit prüfen

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

The American journal of gastroenterology, 2008-05, Vol.103 (5), p.1203-1209

2008

Link zum Volltext

Verfügbarkeit prüfen

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1730-1732

Kornbluth, Asher

2020

Link zum Volltext

Verfügbarkeit prüfen

Double balloon enteroscopy in Crohn's disease: background and current state of play

Current drug targets, 2012-09, Vol.13 (10), p.1280

2012

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

The New England journal of medicine, 1994-06, Vol.330 (26), p.1841-1845

1994

Link zum Volltext

Verfügbarkeit prüfen

Visible dysplasia: what you see is most of what you get

Gastrointestinal endoscopy, 2007-06, Vol.65 (7), p.1005-1006

Kornbluth, Asher, MD

2007

Link zum Volltext

Verfügbarkeit prüfen

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

The American journal of gastroenterology, 2006-07, Vol.101 (7), p.1546-1550

2006

Link zum Volltext

Verfügbarkeit prüfen

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

Clinical gastroenterology and hepatology, 2012-09, Vol.10 (9), p.1002-1007

2012

Link zum Volltext

Verfügbarkeit prüfen

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents

Inflammatory bowel diseases, 2010-12, Vol.16 (S1), p.S1-S11

2010

Link zum Volltext

Verfügbarkeit prüfen

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Inflammatory bowel diseases, 2020-11, Vol.26 (11), p.1779-1785

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Gut, 2014-01, Vol.63 (1), p.88-95

2014

Link zum Volltext

Verfügbarkeit prüfen

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

The American journal of gastroenterology, 2017-11, Vol.112 (11), p.1719-1721

2017

Link zum Volltext

Verfügbarkeit prüfen

Response to Dr. Spada and Colleagues

The American journal of gastroenterology, 2007-07, Vol.102 (7), p.1543-1544

2007

Link zum Volltext

Verfügbarkeit prüfen

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Inflammatory bowel diseases, 2016-10, Vol.22 (10), p.2513-2526

2016

Link zum Volltext

Verfügbarkeit prüfen

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Inflammatory bowel diseases, 2011-02, Vol.17 (2), p.599-604

2011

Link zum Volltext

Verfügbarkeit prüfen

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Clinical gastroenterology and hepatology, 2008-10, Vol.6 (10), p.1112-1116

2008

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

Inflammatory bowel diseases, 2022-07, Vol.28 (7), p.1126-1129

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Gastroenterology (New York, N.Y. 1943), 2013-11, Vol.145 (5), p.978-986.e5

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(60)
Buchkapitel
(1)

Sprache

Englisch
(61)
Japanisch
(10)

Erscheinungsjahr

n.n

Thema

Science & Technology
(61)
Gastroenterology & Hepatology
(56)
Humans
(52)
Female
(29)
Adult
(27)
Male
(27)
Biological And Medical Sciences
(20)
Medical Sciences
(20)
Gastroenterology
(18)
Middle Aged
(18)
Crohn's Disease
(15)
Gastroenterology. Liver. Pancreas. Abdomen
(15)
Other Diseases. Semiology
(15)
Stomach. Duodenum. Small Intestine. Colon. Rectum. Anus
(15)
Inflammatory Bowel Disease
(13)
Treatment Outcome
(13)
Crohn Disease - Drug Therapy
(11)
Colitis, Ulcerative - Drug Therapy
(10)
Ulcerative Colitis
(10)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee

The Role of the Gastroenterologist in Obesity Management: Now Is the Right Time for Our Involvement

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

Histologic Inflammation Is a Risk Factor for Progression to Colorectal Neoplasia in Ulcerative Colitis: A Cohort Study

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

The Risk of Retention of the Capsule Endoscope in Patients with Known or Suspected Crohn's Disease

Relapses of Inflammatory Bowel Disease During Pregnancy: In-Hospital Management and Birth Outcomes

Histologic Healing in Ulcerative Colitis: Benefits. And Risks. Was Voltaire Right?

Double balloon enteroscopy in Crohn's disease: background and current state of play

Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid Therapy

Visible dysplasia: what you see is most of what you get

Do Guidelines Matter? Implementation of the ACG and AGA Osteoporosis Screening Guidelines in Inflammatory Bowel Disease (IBD) Patients Who Meet the Guidelines' Criteria

Patients Enrolled in Randomized Controlled Trials Do Not Represent the Inflammatory Bowel Disease Patient Population

Clinical scenarios in IBD: Optimizing the use of conventional and biologic agents

Management of Inflammatory Bowel Disease and COVID-19 in New York City 2020: The Epicenter of IBD in the First Epicenter of the Global Pandemic

Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial

Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice

Yes, We Are Still Talking about Cylosporin vs. Infliximab in Steroid Resistant Acute Severe Ulcerative Colitis

Response to Dr. Spada and Colleagues

A Critical Review of Biosimilars in IBD: The Confluence of Biologic Drug Development, Regulatory Requirements, Clinical Outcomes, and Big Business

Are your patients taking their medicine? Validation of a new adherence scale in patients with inflammatory bowel disease and comparison with physician perception of adherence

Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

Cyclosporine and Infliximab as Rescue Therapy for Each Other in Patients With Steroid-Refractory Ulcerative Colitis

Outcomes of COVID-19 Infections in Vaccinated Patients with Inflammatory Bowel Disease: Data From an International Registry

Validation of Endoscopic Activity Scores in Patients With Crohn's Disease Based on a Post Hoc Analysis of Data From SONIC

Aktive Filter

Suchergebnisse filtern